|
Indian Pediatr 2010;47: 168-170 |
 |
Association Between Neuropsychiatric Morbidity
and Streptococcal Infections in Children |
S Viswanathan, PD Moses, S Varkki, PS
Russell* and KN Brahmadathan†
From the Departments of Child Health, Child and
Adolescent Psychiatry,* and Microbiology†
,
Christian Medical College, Vellore, Tamil Nadu, India.
Correspondence to: Dr Prabhakar D Moses, Professor and
Head, Department of Child Health Unit III, Christian Medical College,
Vellore 632 004, Tamil Nadu, India.
Email: [email protected]
Received: February 27, 2007;
Initial review: May 21,
2007;
Accepted: October 10, 2008.
Published online: 2009 April 15.
PII:S097475590700132-2
|
Abstract
We conducted a case control study to study the
association between neuropsychiatric morbidity and group A streptococcal
infections in children. Twenty two cases of neuropsychiatric morbidity
were compared with 64 controls. Fourteen (63.6%) of the 22 cases were
positive for ASO and/or ADNB while 21 of the 64 controls (32.8%) were
positive for either or both antibodies (OR = 3.428; CI: 1.15 – 10.18;
P=0.026). We conclude that there is a statistically significant
association between neuropsychiatric morbidity and streptococcal
infection in children.
Key words: Neuropsychiatric disorders, Streptococcal infection,
PANDAS.
|
P ediatric autoimmune
neuropsychiatric disorder associated with Group A streptococcal infection
(PANDAS) is an intriguing clinical entity. Longitudinal follow up of
children with obsessive compulsive disorder (OCD) revealed that a subgroup
had an episodic course characterized by acute exacerbations following
group A streptococcal (GAS) infections(1-5). These observations led to the
proposal of a unique subgroup of patients with neuropsychiatric disorders
that could be identified by certain diagnostic criteria(6). We conducted a
case-control study to assess the significance of our observation(7).
Methods
Children aged 4-16 years attending the outpatient
clinic at Christian Medical College (CMC), Vellore and found to be
positive on Child Behaviour Check List (CBCL) screening for any
neuropsychiatric disorder that is in the spectrum of PANDAS were selected.
Children with organic brain syndromes or progressive neurologic illness
and those with a history of rheumatic fever were excluded. If CBCL was
positive, diagnosis was confirmed by a child and adolescent psychiatrist
based on Diagnostic and Statistical Manual-IV (DSM IV) criteria(8). Age
and sex matched controls were enrolled from the out-patients clinic by
screening every fifth child. For every case, three controls were enrolled.
Blood samples were collected for determining anti-streptolysin
O (ASO), anti-deoxyribonuclease B (ADNB), anti-nuclear antibodies (ANA),
lead, and ceruloplasmin, after obtaining informed consent from the
parents. ASO and ADNB titres were measured by a nephelometric technique.
ANA was estimated by an immunoflourescent technique. Cut-off values for
ASO and ADNB were 300 U/mL and 500 U/mL, respectively. Lead and
ceruloplasmin levels were determined by standard methods(9). ASO/ADNB
titers in cases and controls were analyzed and compared by Chi square test
and Odd’s Ratio at 95% confidence interval.
The CBCL is a questionnaire on childhood
psychopathology used extensively by clinicians to identify somatic
complaints, withdrawn, anxious/depressed symptoms, social problems,
thought problems, attention problems, delinquent behaviors, aggressive
behaviors, as well as sexual problems in 4-16 year individuals. It is
partly validated for the Indian population. It has 113 items scored on a
Likert scale(8). Diagnostic and Statistical Manual-IV edition (DSM-IV)
comprises the clinical criteria available for diagnosing various child
psychiatric disorders and is considered as the reference standard for
making clinical diagnosis in this population(10).
Results
Twenty two children (20 boys, 2 girls) with
neuropsychiatric morbidity and 64 age and sex matched controls (58 boys, 6
girls) were included. Amongst the cases, 7 boys and 1 girl were 4-10 years
of age, while 13 boys and 1 girl were older than 10 years of age. Amongst
the controls, 21 boys and 3 girls were 4-10 years of age while 37 boys and
3 girls were older than 10 years of age.
Of the 22 cases, 6 had OCD, 6 tic disorder, 5
somatoform disorder, 2 each had trichotillomania and ADHD, while one had
parasomnia. Of the 64 controls, 24 (37.5%) had respiratory illness, 13
(20.3%) had neurologic illness and 27 (42.2%) children had other unrelated
conditions.
Fourteen out of 22 cases were positive for ASO/ADNB.
This was significantly more than that in control group, where 21 out of 64
children were found positive (OR=3.43, CI: 1.15-10.18, P=0.026).
Discussion
GAS infections being highly endemic in India, it is
likely that the prevalence of PANDAS is relatively higher as compared to
non-endemic regions; however, very little information regarding this is
available in the Indian literature. Sankaranarayanan and John(11) observed
that one needs to be alert to the possibility of OCD arising secondary to
GAS infections in India. Hence a study was undertaken to identify children
who come under the definition of PANDAS.
Among cases, boys outnumbered girls by a ratio of 11:1.
Higher prevalence of PANDAS among boys has been reported by Swedo, et
al.(3), although the observed ratio was only 2.6:1. The mean
age of the cases was 11.5 years. Interestingly, in epidemiological studies
carried out in a south Indian setting, GAS infections have been found to
be generally higher among boys in the 5-15 year age group(12). It is also
well established that rheumatic fever tends to occur maximally in the 5-15
year age group. These data indicate that children in this age group could
be best targeted for studying the prevalence of PANDAS in our population.
CBCL score was significant enough to suggest
neuropsychiatric morbidity in all 22 cases and were confirmed with DSM-IV
interviews. Screening them for other systemic causes of neuropsychiatric
morbidity like Wilson disease, lead poisoning and collagen vascular
disease did not bring out any definitive diagnosis. Determination of
anti-streptococcal antibodies is a very valuable tool for the confirmation
of GAS pharyngitis and its differentiation from viral pharyngitis(13). A
combination of both ASO and ADNB titers will give >95% specificity and
sensitivity to diagnose streptococcal infections. In the present study,
laboratory evidence of GAS infection was seen in 63.6% of cases as
compared to 32.8% of controls. This was statistically highly significant.
In conclusion, our study identified a group of children
with neuropsychiatric morbidity with no other systemic causes and with a
statistically significant evidence of recent GAS infection. Elevated ASO/ADNB
response may not prove a causal association, but it may be a pointer
towards its probable etiology. Follow-up of these children on a long term
basis may help to prove a causal and temporal association with GAS
infection and its role in the diagnostic validation of PANDAS.
Contributors: SV collected the data, recruited the
controls and executed the study. PDM conceived and planned the study. SV
was involved in the planning and execution of the study. PR confirmed the
cases and contributed to the preparation of the manuscript. KNB performed
the streptococcal antibody tests and prepared the manuscript.
Funding: CMC Fluid Research Grant.
Competing interests: None stated.
What This Study Adds?
• There is a
statistically significant association between neuropsychiatric
morbidity and streptococcal infections in children.
|
References
1. Kiessling LS. Tic disorders with evidence of
invasive group A beta hemolytic streptococcal disease. Dev Med Child
Neurol 1989; 31(Suppl 59): 48.
2. Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub
EM, Hosier DM, et al. High prevalence of obsessive-compulsive
symptoms in patients with Sydenham’s chorea. Am J Psychiatry 1989; 146:
246-249.
3. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen
AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric
disorders associated with strepto-coccal infections: clinical description
of the first 50 cases. Am J Psychiatry 1998; 155: 264-271.
4. Swedo SE, Grant PJ. PANDAS: a model for human
autoimmune disease. J Child Psychol Psychiatry 2005; 46: 227-234.
5. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal
antibodies in movement disorders. Pediatrics 1993; 92: 39-43.
6. Asbahr FR, Negrao BA, Gentil V, Zanetta DMT, da Paz
JA, Marques-Dias MJ, et al. Obsessive compulsive and related
symptoms in children and adolescents with rheumatic fever with and without
chorea: a prospective 6 months study. Am J Psychiatry 1998; 155:
1122-1124.
7. Perrin EM, Murphy ML, Casey JR, Pichichero ME,
Runyan DK, Miller WC, et al. Does group A beta-hemolytic
streptococcal infection increase risk for behavioral and neuropsychiatric
symptoms in children? Arch Pediatr Adolesc Med 2004;158: 848-856.
8. Achemback TM, Edelbrock C. Manual for the Child
Behaviour check list and revised Child Behaviour Profile. Burlington, VT:
Department of Psychiatry, University of Vermont; 1983.
9. Zinterhofer LJM, Jatlow PI, Fappiano A. Atomic
absorption determination of lead in blood and urine in the presence of
EDTA. J Lab Clin Med 1971; 78: 664- 674.
10. American Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders, 4th ed, Washington DC: APA; 1994.
11. Sankaranarayanan A, John JK. Paediatric autoimmune
neuropsychiatric disorder (PANDAS): A case report. Natl Med J India
2003; 16: 22-23.
12. Koshi G, Benjamin V. Surveillance of strepto-coccal
infections in children in a south Indian community – a pilot study. Indian
J Med Res 1981; 66: 379-388.
13. Koshi G. Microbiological confirmation of streptococcal pharyngitis.
ICMR Bull 1982; 12: 11-14.
|
|
 |
|